Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Respirology Case Reports|May 15, 2024
A case of community-acquired pneumonia caused by Bacillus subtilis subsp. natto in an immunocompetent patientTetsuo Tani, Tomohiro Takehara, Kota Ishioka, et al.
Case Reports in Nephrology and Dialysis|October 30, 2023
Chryseobacterium indologenes Peritonitis in a Peritoneal Dialysis Patient: A Case Report and Review of LiteratureAkira Miyakawa, Kentaro Fujii, Ai Kato, et al.
Clinical and Experimental Nephrology|January 7, 2023
Canagliflozin protects the cardiovascular system through effects on the gut environment in non-diabetic nephrectomized ratsAyumi Matsui, Ayumi Yoshifuji, Junichiro Irie, et al.
Renal Replacement Therapy|May 26, 2022
Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19Masataro Toda, Ayumi Yoshifuji, Kentaro Fujii, et al.
Clinical and Experimental Nephrology|August 26, 2021
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patientsMasataro Toda, Kentaro Fujii, Ayumi Yoshifuji, et al.
Internal Medicine (Tokyo, Japan)|December 25, 2024
A Case of Membranous Nephropathy Associated with Syphilis: Correlative Light and Electron Microscopy Revealing the Localization of Neuron-derived Neurotrophic Factor within Subepithelial Electron Dense DepositsChisato Minezaki, Tatsuhiko Azegami, Akinori Hashiguchi, et al.
Clinical and Experimental Nephrology|April 21, 2018
Oral adsorbent AST-120 ameliorates gut environment and protects against the progression of renal impairment in CKD ratsAyumi Yoshifuji, Shu Wakino, Junichiro Irie, et al.
Kidney International|March 4, 2019
β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effectsTakaya Tajima, Ayumi Yoshifuji, Ayumi Matsui, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 22, 2015
Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in ratsAyumi Yoshifuji, Shu Wakino, Junichiro Irie, et al.
Japanese Journal of Infectious Diseases|May 1, 2022
Nafamostat Mesylate Monotherapy in Patients with Moderate COVID-19: a Single-Center, Retrospective StudyTomomi Soma, Kentaro Fujii, Ayumi Yoshifuji, et al.
Pageof 4